MATE Act of 2021

I 117TH CONGRESS 1ST SESSION H. R. 2067 To amend the Controlled Substances Act to require physicians and other prescribers of controlled substances to complete training on treating and managing patients with opioid and other substance use disorders, and for other purposes. IN THE HOUSE OF REPRESENTATIVES MARCH 18, 2021 Mrs. TRAHAN (for herself, Mr. CARTER of Georgia, Mr. MCKINLEY, Ms. KUSTER, Mr. TRONE, and Mr. TONKO) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subse- quently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Controlled Substances Act to require physi- cians and other prescribers of controlled substances to complete training on treating and managing patients with opioid and other substance use disorders, and for other purposes. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 VerDate Sep 11 2014 04:47 May 19, 2021 Jkt 019200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H2067.IH H2067 kjohnson on DSK79L0C42PROD with BILLS 2 •HR 2067 IH SECTION 1. SHORT TITLE. 1 This Act may be cited as the ‘‘Medication Access and 2 Training Expansion Act of 2021’’ or the ‘‘MATE Act of 3 2021’’. 4 SEC. 2. REQUIRING PRESCRIBERS OF CONTROLLED SUB- 5 STANCES TO COMPLETE TRAINING ON 6 TREATING AND MANAGING PATIENTS WITH 7 OPIOID AND OTHER SUBSTANCE USE DIS- 8 ORDERS. 9 Section 303 of the Controlled Substances Act (21 10 U.S.C. 823) is amended by adding at the end the fol- 11 lowing: 12 ‘‘(l) REQUIRED TRAINING FOR PRESCRIBERS ON 13 TREATING AND MANAGING PATIENTS WITH OPIOID AND 14 OTHER SUBSTANCE USE DISORDERS.— 15 ‘‘(1) APPLICABILITY.—This subsection ap- 16 plies— 17 ‘‘(A) with respect to any practitioner who 18 is licensed under State law to prescribe con- 19 trolled substances and is not a veterinarian or 20 a dentist; and 21 ‘‘(B) beginning with the first registration 22 or renewal of registration by the practitioner 23 under this section occurring 180 or more days 24 after the date of enactment of the Medication 25 Access and Training Expansion Act of 2021. 26 VerDate Sep 11 2014 04:47 May 19, 2021 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H2067.IH H2067 kjohnson on DSK79L0C42PROD with BILLS 3 •HR 2067 IH ‘‘(2) TRAINING REQUIRED.—As a condition on 1 registration under this section to dispense controlled 2 substances in schedule II, III, IV, or V, the Attorney 3 General shall require any practitioner described in 4 paragraph (1)(A) to meet the following: 5 ‘‘(A) If the practitioner is a physician, the 6 practitioner must meet one or more of the fol- 7 lowing conditions: 8 ‘‘(i) The physician holds a board cer- 9 tification in addiction psychiatry or addic- 10 tion medicine from the American Board of 11 Medical Specialties. 12 ‘‘(ii) The physician holds a board cer- 13 tification from the American Board of Ad- 14 diction Medicine. 15 ‘‘(iii) The physician holds a board cer- 16 tification in addiction medicine from the 17 American Osteopathic Association. 18 ‘‘(iv) The physician has, with respect 19 to the treatment and management of pa- 20 tients with opioid or other substance use 21 disorders, completed not less than 8 hours 22 of training (through classroom situations, 23 seminars at professional society meetings, 24 VerDate Sep 11 2014 04:47 May 19, 2021 Jkt 019200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H2067.IH H2067 kjohnson on DSK79L0C42PROD with BILLS 4 •HR 2067 IH electronic communications, or otherwise) 1 that is provided by— 2 ‘‘(I) the American Society of Ad- 3 diction Medicine, the American Acad- 4 emy of Addiction Psychiatry, the 5 American Medical Association, the 6 American Osteopathic Association, the 7 American Psychiatric Association, or 8 any other organization accredited by 9 the Accreditation Council for Con- 10 tinuing Medical Education (commonly 11 known as the ‘ACCME’); 12 ‘‘(II) any organization accredited 13 by a State medical society accreditor 14 recognized by the ACCME; or 15 ‘‘(III) any organization accred- 16 ited by the American Osteopathic As- 17 sociation to provide continuing med- 18 ical education. 19 ‘‘(v) The physician graduated in good 20 standing from an accredited school of 21 allopathic medicine or osteopathic medicine 22 in the United States during the 5-year pe- 23 riod immediately preceding the date on 24 which the physician first registers or re- 25 VerDate Sep 11 2014 04:47 May 19, 2021 Jkt 019200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H2067.IH H2067 kjohnson on DSK79L0C42PROD with BILLS 5 •HR 2067 IH news under this section and has success- 1 fully completed a comprehensive allopathic 2 or osteopathic medicine curriculum or ac- 3 credited medical residency that included 4 not less than 8 hours of training on treat- 5 ing and managing patients with opioid and 6 other substance use disorders, including 7 the appropriate clinical use of all drugs ap- 8 proved by the Food and Drug Administra- 9 tion for the treatment of a substance use 10 disorder. 11 ‘‘(B) If the practitioner is not a physician, 12 the practitioner must meet one or more of the 13 following conditions: 14 ‘‘(i) Completed not fewer than 8 hours 15 of training with respect to the treatment 16 and management of patients with opioid or 17 other substance use disorders (through 18 classroom situations, seminars at profes- 19 sional society meetings, electronic commu- 20 nications, or otherwise) provided by the 21 American Society of Addiction Medicine, 22 the American Academy of Addiction Psy- 23 chiatry, the American Medical Association, 24 the American Osteopathic Association, the 25 VerDate Sep 11 2014 04:47 May 19, 2021 Jkt 019200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H2067.IH H2067 kjohnson on DSK79L0C42PROD with BILLS 6 •HR 2067 IH American Nurses Credentialing Center, the 1 American Psychiatric Association, the 2 American Association of Nurse Practi- 3 tioners, the American Academy of Physi- 4 cian Assistants, or any other organization 5 that the Secretary determines is appro- 6 priate for purposes of this clause. 7 ‘‘(ii) Graduated in good standing from 8 an accredited physician assistant school or 9 accredited school of advanced practice 10 nursing in the United States during the 5- 11 year period immediately preceding the date 12 on which the practitioner first registers or 13 renews under this section and has success- 14 fully completed a comprehensive physician 15 assistant or advanced practice nursing cur- 16 riculum that included not less than 8 hours 17 of training on treating and managing pa- 18 tients with opioid and other substance use 19 disorders, including the appropriate clinical 20 use of all drugs approved by the Food and 21 Drug Administration for the treatment of 22 a substance use disorder. 23 ‘‘(3) ONE-TIME TRAINING.—The Attorney Gen- 24 eral shall not require any practitioner to complete 25 VerDate Sep 11 2014 04:47 May 19, 2021 Jkt 019200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H2067.IH H2067 kjohnson on DSK79L0C42PROD with BILLS 7 •HR 2067 IH the training described in clause (iv) or (v) of para- 1 graph (2)(A) or clause (i) or (ii) of paragraph 2 (2)(B) more than once. 3 ‘‘(4) RULE OF CONSTRUCTION.—Nothing in 4 this subsection shall be construed to prevent a prac- 5 titioner from using the same training both for pur- 6 poses of satisfying the registration requirement of 7 this subsection and for other purposes, such as satis- 8 fying State licensing requirements.’’. 9 SEC. 3. PRACTITIONER EDUCATION GRANT PROGRAM. 10 Title V of the Public Health Service Act is amended 11 by inserting after section 509 of such Act (42 U.S.C. 12 290bb–2) the following: 13 ‘‘SEC. 510. PRACTITIONER EDUCATION GRANT PROGRAM. 14 ‘‘(a) IN GENERAL.—The Secretary shall carry out a 15 program to award grants to eligible entities to expand the 16 integration of substance use disorder education into the 17 standard curriculum of relevant health care and health 18 services education programs, thereby expanding the num- 19 ber of practitioners who deliver high-quality, evidence- 20 based substance use disorder treatment. 21 ‘‘(b) ELIGIBLE ENTITIES.—To be eligible to receive 22 a grant under this section, an entity shall be— 23 ‘‘(1) a private nonprofit or public professional 24 association representing health care professionals in 25 VerDate Sep 11 2014 04:47 May 19, 2021 Jkt 019200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\H2067.IH H2067 kjohnson on DSK79L0C42PROD with BILLS 8 •HR 2067 IH the field of medicine, physician assistants, nursing, 1 social work, psychology, marriage and family ther- 2 apy, or health services administration; or 3 ‘‘(2) a private nonprofit or public entity that is 4 a university, college, or other professional school. 5 ‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—To 6 carry out this section, there is authorized to be appro- 7 priated such sums as may be necessary for each of fiscal 8 years 2022 through 2027.’’. 9 Æ VerDate Sep 11 2014 04:47 May 19, 2021 Jkt 019200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6301 E:\BILLS\H2067.IH H2067 kjohnson on DSK79L0C42PROD with BILLS